AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8400
-0.0200 (-2.33%)
At close: Jul 11, 2025, 4:00 PM
0.8348
-0.0052 (-0.62%)
After-hours: Jul 11, 2025, 8:00 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $9.50 million as of July 11, 2025. Its market cap has decreased by -75.97% in one year.
Market Cap
9.50M
Enterprise Value
13.65M
1-Year Change
-75.97%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $9.50M, a decrease of -85.08%. That is a compound annual growth rate of -36.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 9.50M | -56.00% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |